Page last updated: 2024-08-24
gallocatechol and Osteogenic Sarcoma
gallocatechol has been researched along with Osteogenic Sarcoma in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Eckard, J; Frenkel, K; Huang, X; Rossman, TG; Wu, J; Yang, C; Yusuf, R; Zhang, P; Zhang, R | 1 |
Other Studies
1 other study(ies) available for gallocatechol and Osteogenic Sarcoma
Article | Year |
---|---|
Caffeic acid phenethyl ester (CAPE) prevents transformation of human cells by arsenite (As) and suppresses growth of As-transformed cells.
Topics: Antioxidants; Apoptosis; Arsenites; Caffeic Acids; Catechin; Cell Growth Processes; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Cytokines; Drug Interactions; Flow Cytometry; Humans; Oligonucleotide Array Sequence Analysis; Osteosarcoma; Phenylethyl Alcohol; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes | 2005 |